Help us: Donate
Follow us on:
×

Menu

Back

Tag: Insilico Medicine

2021 on a stethoscope
January 15, 2021
The world of rejuvenation biotechnology is a rapidly changing and ever developing place. As with any disruptive technology, the challenges are significant and include not only the technical aspects of developing these technologies but also the hurdles of societal acceptance of the desirability of longer, healthier lives. While I do not accept the idea proposed...
Taisho Pharmaceutical logo
October 16, 2020
Insilico Medicine has announced a historic deal with the Taisho Pharmaceutical Company, which is based in Japan, in a partnership to identify and develop new senolytic drugs. The companies have agreed to collaborate on AI-powered drug discovery focused on identifying molecules to remove problematic senescent cells. Cellular SenescenceAs your body ages, more of your cells...
Alex Zhavoronkov interview
April 22, 2020
In this 80-minute interview with Brent Nally, Dr. Alex Zhavoronkov of Insilico Medicine discusses the relationship between COVID-19 and age-related diseases, including how this 'gerophilic' disease primarily afflicts the elderly, how COVID-19 has affected research on aging, and many related topics, including how extending lifespan without extending healthspan puts our society at risk of hyperinflation...
December 05, 2019
A type of artificial intelligence technique is now being used to develop new drugs and therapies and could perhaps even help to solve aging. An urgent need for aging biomarkers There has long been an urgent need in our field to develop increasingly accurate biomarkers of aging so that the efficacy of interventions can be...
October 14, 2019
We're continuing to release talks from Ending Age-Related Diseases 2019, our highly successful two-day conference that featured talks from leading researchers and investors, bringing them together to discuss the future of aging and rejuvenation biotechnology. Dr. Qingsong Zhu, the COO of Insilico Medicine, discussed the use of deep learning in creating biomarkers for aging. Initially...
September 02, 2019
Insilico Medicine has achieved a world first by successfully designing, synthesizing, and validating a new drug from the ground up and taking just 46 days to do so. It achieved this impressive feat using AI. This is the first time that AI has been used to successfully create a new drug, and it took record...